The Latin America, Middle East and Africa Artificial Intelligence In Precision Medicine Market should witness market growth of 35.4% CAGR during the forecast period (2022-2028).
Precision medicine has already produced significant new findings and FDA-approved therapies that are tailored to a person's unique traits, such as their genetic makeup or the genetic profile of their tumor. Molecular testing is frequently administered to patients with different types of cancer as part of patient care, allowing medical professionals to choose therapies that raise survival rates and lower the risk of side effects.
The market for precision medicine is developing due to the increasing R&D expenditures and increased demand for customized drugs. Collaboration amongst important businesses is further propelling the industry's growth. As an illustration, in August 2022, Sanofi and Atomwise reached an agreement for USD 20 million, and Sanofi planned to utilize Atomwise's AtomNet system for research and computational discovery study on up to five therapeutic targets.
The platform incorporates deep learning-based components for the structure-based designing of pharmaceuticals through quick, AI-powered searches of the company's exclusive library of more than three trillion synthesizable complexes.
Qatar has a pretty special chance to lead precision health due to its highly homogenous gene pool and prevalent in-group illnesses. Precision medicine will benefit greatly from the development of machine learning (ML), artificial intelligence (AI), deep learning (DL), and big data analytics. Additionally, wearable sensors and information and communication technology, in general, are fostering a higher degree of precision in healthcare. The implementation of personalized healthcare efforts in Qatar is a component of a coordinated and all-encompassing precision medicine approach.
The Brazil market dominated the LAMEA Artificial Intelligence in Precision Medicine Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $99.7 Million by 2028.The Argentina market is experiencing a CAGR of 36.1% during (2022-2028). Additionally, The UAE market would display a CAGR of 35% during (2022-2028).
Based on Application, the market is segmented into Oncology, Cardiology, Neurology, Respiratory and Others. Based on Component, the market is segmented into Software, Hardware and Service. Based on Technology, the market is segmented into Deep Learning, Natural Language Processing, Querying Method and Context Aware Processing. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Sanofi S.A., NVIDIA Corporation, Intel Corporation, Microsoft Corporation, IBM Corporation, Google LLC (Alphabet Inc.), AstraZeneca PLC, and Tempus, Inc.
Precision medicine has already produced significant new findings and FDA-approved therapies that are tailored to a person's unique traits, such as their genetic makeup or the genetic profile of their tumor. Molecular testing is frequently administered to patients with different types of cancer as part of patient care, allowing medical professionals to choose therapies that raise survival rates and lower the risk of side effects.
The market for precision medicine is developing due to the increasing R&D expenditures and increased demand for customized drugs. Collaboration amongst important businesses is further propelling the industry's growth. As an illustration, in August 2022, Sanofi and Atomwise reached an agreement for USD 20 million, and Sanofi planned to utilize Atomwise's AtomNet system for research and computational discovery study on up to five therapeutic targets.
The platform incorporates deep learning-based components for the structure-based designing of pharmaceuticals through quick, AI-powered searches of the company's exclusive library of more than three trillion synthesizable complexes.
Qatar has a pretty special chance to lead precision health due to its highly homogenous gene pool and prevalent in-group illnesses. Precision medicine will benefit greatly from the development of machine learning (ML), artificial intelligence (AI), deep learning (DL), and big data analytics. Additionally, wearable sensors and information and communication technology, in general, are fostering a higher degree of precision in healthcare. The implementation of personalized healthcare efforts in Qatar is a component of a coordinated and all-encompassing precision medicine approach.
The Brazil market dominated the LAMEA Artificial Intelligence in Precision Medicine Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $99.7 Million by 2028.The Argentina market is experiencing a CAGR of 36.1% during (2022-2028). Additionally, The UAE market would display a CAGR of 35% during (2022-2028).
Based on Application, the market is segmented into Oncology, Cardiology, Neurology, Respiratory and Others. Based on Component, the market is segmented into Software, Hardware and Service. Based on Technology, the market is segmented into Deep Learning, Natural Language Processing, Querying Method and Context Aware Processing. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Sanofi S.A., NVIDIA Corporation, Intel Corporation, Microsoft Corporation, IBM Corporation, Google LLC (Alphabet Inc.), AstraZeneca PLC, and Tempus, Inc.
Scope of the Study
By Application
- Oncology
- Cardiology
- Neurology
- Respiratory
- Others
By Component
- Software
- Hardware
- Service
By Technology
- Deep Learning
- Natural Language Processing
- Querying Method
- Context Aware Processing
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- General Electric (GE) Co. (GE Healthcare)
- Sanofi S.A.
- NVIDIA Corporation
- Intel Corporation
- Microsoft Corporation
- IBM Corporation
- Google LLC (Alphabet Inc.)
- AstraZeneca PLC
- Tempus, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Artificial Intelligence in precision Medicine Market, by Application
1.4.2 LAMEA Artificial Intelligence in precision Medicine Market, by Component
1.4.3 LAMEA Artificial Intelligence in precision Medicine Market, by Technology
1.4.4 LAMEA Artificial Intelligence in precision Medicine Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.3 Market Share Analysis, 2021
3.4 Top Winning Strategies
3.4.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.4.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Jan - 2022, Nov) Leading Players
Chapter 4. LAMEA Artificial Intelligence in Precision Medicine Market by Application
4.1 LAMEA Oncology Market by Country
4.2 LAMEA Cardiology Market by Country
4.3 LAMEA Neurology Market by Country
4.4 LAMEA Respiratory Market by Country
4.5 LAMEA Others Market by Country
Chapter 5. LAMEA Artificial Intelligence in Precision Medicine Market by Component
5.1 LAMEA Software Market by Country
5.2 LAMEA Hardware Market by Country
5.3 LAMEA Service Market by Country
Chapter 6. LAMEA Artificial Intelligence in Precision Medicine Market by Technology
6.1 LAMEA Deep Learning Market by Country
6.2 LAMEA Natural Language Processing Market by Country
6.3 LAMEA Querying Method Market by Country
6.4 LAMEA Context Aware Processing Market by Country
Chapter 7. LAMEA Artificial Intelligence in Precision Medicine Market by Country
7.1 Brazil Artificial Intelligence In Precision Medicine Market
7.1.1 Brazil Artificial Intelligence In Precision Medicine Market by Application
7.1.2 Brazil Artificial Intelligence In Precision Medicine Market by Component
7.1.3 Brazil Artificial Intelligence In Precision Medicine Market by Technology
7.2 Argentina Artificial Intelligence in Precision Medicine Market
7.2.1 Argentina Artificial Intelligence in Precision Medicine Market by Application
7.2.2 Argentina Artificial Intelligence in Precision Medicine Market by Component
7.2.3 Argentina Artificial Intelligence in Precision Medicine Market by Technology
7.3 UAE Artificial Intelligence in Precision Medicine Market
7.3.1 UAE Artificial Intelligence in Precision Medicine Market by Application
7.3.2 UAE Artificial Intelligence in Precision Medicine Market by Component
7.3.3 UAE Artificial Intelligence in Precision Medicine Market by Technology
7.4 Saudi Arabia Artificial Intelligence in Precision Medicine Market
7.4.1 Saudi Arabia Artificial Intelligence in Precision Medicine Market by Application
7.4.2 Saudi Arabia Artificial Intelligence in Precision Medicine Market by Component
7.4.3 Saudi Arabia Artificial Intelligence in Precision Medicine Market by Technology
7.5 South Africa Artificial Intelligence in Precision Medicine Market
7.5.1 South Africa Artificial Intelligence in Precision Medicine Market by Application
7.5.2 South Africa Artificial Intelligence in Precision Medicine Market by Component
7.5.3 South Africa Artificial Intelligence in Precision Medicine Market by Technology
7.6 Nigeria Artificial Intelligence in Precision Medicine Market
7.6.1 Nigeria Artificial Intelligence in Precision Medicine Market by Application
7.6.2 Nigeria Artificial Intelligence in Precision Medicine Market by Component
7.6.3 Nigeria Artificial Intelligence in Precision Medicine Market by Technology
7.7 Rest of LAMEA Artificial Intelligence in Precision Medicine Market
7.7.1 Rest of LAMEA Artificial Intelligence in Precision Medicine Market by Application
7.7.2 Rest of LAMEA Artificial Intelligence in Precision Medicine Market by Component
7.7.3 Rest of LAMEA Artificial Intelligence in Precision Medicine Market by Technology
Chapter 8. Company Profiles
8.1 General Electric (GE) Co. (GE Healthcare)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.6 SWOT Analysis
8.2 Google LLC (Alphabet Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.6 SWOT Analysis
8.3 Intel Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 SWOT Analysis
8.4 Microsoft Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 IBM Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional & Segmental Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 NVIDIA Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.6 SWOT Analysis
8.7 AstraZeneca PLC
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Sanofi S.A.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 Tempus, Inc.
8.9.1 Company Overview
Companies Mentioned
- General Electric (GE) Co. (GE Healthcare)
- Sanofi S.A.
- NVIDIA Corporation
- Intel Corporation
- Microsoft Corporation
- IBM Corporation
- Google LLC (Alphabet Inc.)
- AstraZeneca PLC
- Tempus, Inc.
Methodology
LOADING...
